alendronate sodium
Idiopathic Pulmonary Fibrosis
Clinical trials
1
Developer
University of North Carolina
Overview
alendronate sodium is an agent tracked by PF-Atlas in the context of idiopathic pulmonary fibrosis. It appears in 1 tracked IPF clinical trial.
alendronate sodium clinical trials
Explore related
Medical disclaimer. This page summarizes research about alendronate sodium for information only. It is not medical advice. Verify approval status and evidence with the FDA and a pulmonologist.